10 Feb 2022 , 08:17 AM
Net profit of Gufic BioSciences rose 36.03% to Rs 21.03 crore in the quarter ended December 2021 as against Rs 15.46 crore during the previous quarter ended December 2020. Sales rose 3.31% to Rs 172.07 crore in the quarter ended December 2021 as against Rs 166.56 crore during the previous quarter ended December 2020.
| Particulars | Quarter Ended | ||
| ? | Dec. 2021 | Dec. 2020 | % Var. |
| Sales | 172.07 | 166.56 | 3 |
| OPM % | 19.01 | 16.46 | – |
| PBDT | 33.21 | 23.66 | 40 |
| PBT | 28.73 | 20.44 | 41 |
| NP | 21.03 | 15.46 | 36 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
